Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 25 | 2019 | 1490 | 3.500 |
Why?
|
Lower Extremity | 15 | 2018 | 1201 | 2.930 |
Why?
|
Ischemia | 20 | 2021 | 1876 | 2.790 |
Why?
|
Peripheral Arterial Disease | 15 | 2024 | 1272 | 2.410 |
Why?
|
Thoracic Outlet Syndrome | 3 | 2021 | 97 | 1.430 |
Why?
|
Endarterectomy, Carotid | 12 | 2022 | 555 | 1.370 |
Why?
|
Carotid Stenosis | 11 | 2022 | 860 | 1.250 |
Why?
|
Economic Competition | 4 | 2016 | 219 | 1.240 |
Why?
|
Limb Salvage | 11 | 2024 | 481 | 1.200 |
Why?
|
Intermittent Claudication | 6 | 2016 | 304 | 1.140 |
Why?
|
Aortic Aneurysm, Abdominal | 9 | 2022 | 1230 | 1.130 |
Why?
|
Peripheral Vascular Diseases | 6 | 2013 | 488 | 1.120 |
Why?
|
Amputees | 2 | 2015 | 91 | 0.900 |
Why?
|
Military Medicine | 4 | 2018 | 185 | 0.880 |
Why?
|
Stents | 12 | 2022 | 3179 | 0.820 |
Why?
|
Quality Indicators, Health Care | 6 | 2019 | 1792 | 0.790 |
Why?
|
Surgical Procedures, Operative | 7 | 2019 | 1923 | 0.760 |
Why?
|
Veins | 5 | 2016 | 768 | 0.760 |
Why?
|
Chi-Square Distribution | 13 | 2017 | 3419 | 0.720 |
Why?
|
Commerce | 2 | 2016 | 606 | 0.690 |
Why?
|
Vascular Patency | 10 | 2016 | 910 | 0.690 |
Why?
|
Leg | 5 | 2013 | 1089 | 0.680 |
Why?
|
Healthcare Disparities | 6 | 2018 | 3357 | 0.670 |
Why?
|
Multivariate Analysis | 19 | 2017 | 12059 | 0.670 |
Why?
|
Angioplasty, Balloon | 5 | 2016 | 588 | 0.670 |
Why?
|
Angioplasty | 4 | 2015 | 354 | 0.660 |
Why?
|
Hematoma | 4 | 2017 | 768 | 0.640 |
Why?
|
Vascular Grafting | 3 | 2024 | 162 | 0.640 |
Why?
|
Blood Vessel Prosthesis Implantation | 8 | 2022 | 1427 | 0.640 |
Why?
|
Postoperative Complications | 17 | 2022 | 15647 | 0.600 |
Why?
|
Seroma | 1 | 2017 | 75 | 0.550 |
Why?
|
Competitive Medical Plans | 1 | 2016 | 26 | 0.530 |
Why?
|
Surgical Wound Infection | 4 | 2017 | 1525 | 0.520 |
Why?
|
Quality of Life | 9 | 2016 | 13355 | 0.510 |
Why?
|
Length of Stay | 10 | 2019 | 6422 | 0.500 |
Why?
|
Patient Discharge | 6 | 2019 | 3438 | 0.500 |
Why?
|
Health Resources | 3 | 2013 | 935 | 0.490 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 257 | 0.480 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.480 |
Why?
|
Treatment Outcome | 47 | 2022 | 64645 | 0.470 |
Why?
|
General Surgery | 5 | 2022 | 1692 | 0.470 |
Why?
|
Risk Assessment | 28 | 2022 | 23981 | 0.460 |
Why?
|
Odds Ratio | 11 | 2017 | 9639 | 0.460 |
Why?
|
Health Care Sector | 1 | 2016 | 194 | 0.460 |
Why?
|
Graft Occlusion, Vascular | 4 | 2024 | 537 | 0.450 |
Why?
|
Time Factors | 30 | 2022 | 39974 | 0.450 |
Why?
|
Specialties, Surgical | 2 | 2018 | 389 | 0.440 |
Why?
|
Phlebography | 1 | 2014 | 326 | 0.440 |
Why?
|
Patient Readmission | 8 | 2019 | 3267 | 0.430 |
Why?
|
Ribs | 1 | 2014 | 252 | 0.430 |
Why?
|
Logistic Models | 14 | 2022 | 13251 | 0.430 |
Why?
|
Alginates | 1 | 2014 | 248 | 0.420 |
Why?
|
Bandages | 1 | 2014 | 269 | 0.410 |
Why?
|
Polyesters | 1 | 2014 | 374 | 0.410 |
Why?
|
Kidney Transplantation | 4 | 2016 | 4236 | 0.410 |
Why?
|
Decision Support Techniques | 3 | 2017 | 1998 | 0.400 |
Why?
|
Facial Transplantation | 1 | 2015 | 221 | 0.400 |
Why?
|
Health Services Needs and Demand | 2 | 2017 | 1403 | 0.400 |
Why?
|
Endovascular Procedures | 6 | 2022 | 2181 | 0.400 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 700 | 0.400 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.400 |
Why?
|
Polyethylenes | 1 | 2014 | 290 | 0.390 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3801 | 0.390 |
Why?
|
Patient Selection | 10 | 2020 | 4244 | 0.390 |
Why?
|
United States | 39 | 2022 | 72317 | 0.390 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 665 | 0.380 |
Why?
|
Aortic Rupture | 2 | 2014 | 319 | 0.380 |
Why?
|
Proportional Hazards Models | 16 | 2016 | 12450 | 0.380 |
Why?
|
Hospital Costs | 2 | 2017 | 948 | 0.370 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1737 | 0.370 |
Why?
|
Aged | 53 | 2024 | 169179 | 0.360 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5439 | 0.360 |
Why?
|
Physician's Role | 1 | 2017 | 916 | 0.350 |
Why?
|
Male | 72 | 2024 | 360621 | 0.350 |
Why?
|
Health Care Costs | 4 | 2017 | 3243 | 0.340 |
Why?
|
Benchmarking | 2 | 2016 | 1045 | 0.330 |
Why?
|
Databases as Topic | 2 | 2011 | 473 | 0.330 |
Why?
|
Exercise Test | 2 | 2015 | 2129 | 0.330 |
Why?
|
Comorbidity | 12 | 2016 | 10498 | 0.330 |
Why?
|
Female | 73 | 2024 | 392485 | 0.330 |
Why?
|
Specialization | 1 | 2014 | 779 | 0.330 |
Why?
|
Hospitals | 3 | 2017 | 3878 | 0.320 |
Why?
|
Wound Healing | 3 | 2017 | 2802 | 0.320 |
Why?
|
Social Behavior | 1 | 2015 | 1134 | 0.320 |
Why?
|
Middle Aged | 51 | 2024 | 220774 | 0.320 |
Why?
|
Quality Improvement | 6 | 2019 | 3800 | 0.320 |
Why?
|
Magnetic Resonance Angiography | 2 | 2014 | 1432 | 0.320 |
Why?
|
Face | 1 | 2015 | 1026 | 0.310 |
Why?
|
Humans | 102 | 2024 | 761326 | 0.310 |
Why?
|
Risk Factors | 32 | 2024 | 74152 | 0.310 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1669 | 0.310 |
Why?
|
Data Mining | 1 | 2013 | 551 | 0.300 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2016 | 198 | 0.300 |
Why?
|
Health Expenditures | 2 | 2017 | 2365 | 0.300 |
Why?
|
Retrospective Studies | 42 | 2024 | 80575 | 0.300 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1419 | 0.290 |
Why?
|
Women | 1 | 2009 | 223 | 0.290 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 2170 | 0.290 |
Why?
|
Kaplan-Meier Estimate | 12 | 2016 | 6473 | 0.280 |
Why?
|
Popliteal Artery | 3 | 2016 | 310 | 0.280 |
Why?
|
Reoperation | 8 | 2019 | 4302 | 0.280 |
Why?
|
Extremities | 2 | 2014 | 867 | 0.280 |
Why?
|
Aged, 80 and over | 25 | 2019 | 58946 | 0.280 |
Why?
|
Military Personnel | 5 | 2020 | 1246 | 0.280 |
Why?
|
Azygos Vein | 1 | 2006 | 19 | 0.280 |
Why?
|
Carotid Artery Diseases | 4 | 2015 | 877 | 0.270 |
Why?
|
Critical Illness | 8 | 2016 | 2722 | 0.270 |
Why?
|
Disability Evaluation | 1 | 2013 | 1836 | 0.260 |
Why?
|
Linear Models | 5 | 2017 | 5871 | 0.260 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 961 | 0.260 |
Why?
|
Social Support | 1 | 2015 | 2172 | 0.250 |
Why?
|
Office Visits | 2 | 2022 | 595 | 0.250 |
Why?
|
Postoperative Hemorrhage | 2 | 2012 | 415 | 0.240 |
Why?
|
Iliac Vein | 1 | 2004 | 70 | 0.240 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7824 | 0.230 |
Why?
|
Graft Survival | 6 | 2016 | 3818 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 2 | 2010 | 807 | 0.230 |
Why?
|
Insurance Benefits | 2 | 2016 | 187 | 0.220 |
Why?
|
Multiple Trauma | 1 | 2006 | 369 | 0.220 |
Why?
|
Databases, Factual | 4 | 2019 | 7954 | 0.220 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2471 | 0.220 |
Why?
|
Liver Transplantation | 1 | 2015 | 2333 | 0.220 |
Why?
|
Pain | 1 | 2018 | 5077 | 0.210 |
Why?
|
Arterial Occlusive Diseases | 3 | 2019 | 748 | 0.200 |
Why?
|
Hospital Mortality | 3 | 2015 | 5291 | 0.200 |
Why?
|
Diagnostic Imaging | 2 | 2014 | 3531 | 0.200 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2017 | 10203 | 0.200 |
Why?
|
Survivors | 1 | 2013 | 2370 | 0.200 |
Why?
|
Sex Factors | 6 | 2018 | 10551 | 0.190 |
Why?
|
Emergencies | 2 | 2019 | 1217 | 0.190 |
Why?
|
Registries | 11 | 2022 | 8223 | 0.190 |
Why?
|
Vascular Diseases | 1 | 2010 | 1161 | 0.190 |
Why?
|
Macrolides | 1 | 2022 | 205 | 0.190 |
Why?
|
Health Facility Environment | 1 | 2021 | 32 | 0.190 |
Why?
|
Hospital Bed Capacity | 2 | 2014 | 206 | 0.190 |
Why?
|
Tissue Donors | 3 | 2016 | 2331 | 0.190 |
Why?
|
Residence Characteristics | 3 | 2017 | 2092 | 0.180 |
Why?
|
Aorta, Thoracic | 2 | 2006 | 1097 | 0.180 |
Why?
|
Stroke | 7 | 2022 | 9749 | 0.180 |
Why?
|
Boston | 7 | 2016 | 9333 | 0.180 |
Why?
|
Femoral Artery | 3 | 2016 | 827 | 0.180 |
Why?
|
California | 2 | 2015 | 1426 | 0.180 |
Why?
|
Diffusion of Innovation | 2 | 2017 | 727 | 0.180 |
Why?
|
Subclavian Artery | 1 | 2021 | 134 | 0.180 |
Why?
|
Insurance | 1 | 2021 | 113 | 0.170 |
Why?
|
Adult | 23 | 2022 | 221122 | 0.170 |
Why?
|
Iliac Artery | 2 | 2019 | 343 | 0.160 |
Why?
|
Insurance Carriers | 1 | 2021 | 156 | 0.160 |
Why?
|
Body Mass Index | 1 | 2017 | 12949 | 0.160 |
Why?
|
Recovery of Function | 4 | 2015 | 2977 | 0.160 |
Why?
|
After-Hours Care | 1 | 2019 | 102 | 0.160 |
Why?
|
Veterans Health | 2 | 2018 | 215 | 0.160 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4063 | 0.160 |
Why?
|
Health Services Research | 3 | 2013 | 1811 | 0.160 |
Why?
|
Cohort Studies | 11 | 2018 | 41440 | 0.150 |
Why?
|
Health Benefit Plans, Employee | 2 | 2019 | 333 | 0.150 |
Why?
|
Aneurysm | 1 | 2021 | 337 | 0.150 |
Why?
|
Renal Insufficiency | 2 | 2014 | 809 | 0.150 |
Why?
|
Ambulatory Care | 2 | 2019 | 2775 | 0.140 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 395 | 0.140 |
Why?
|
Medicare | 6 | 2022 | 6758 | 0.140 |
Why?
|
Incidence | 8 | 2016 | 21336 | 0.140 |
Why?
|
Comparative Effectiveness Research | 3 | 2022 | 709 | 0.140 |
Why?
|
Analgesia, Epidural | 1 | 2019 | 332 | 0.130 |
Why?
|
Research Design | 5 | 2021 | 6178 | 0.130 |
Why?
|
Trust | 1 | 2021 | 530 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2015 | 39108 | 0.130 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2022 | 781 | 0.130 |
Why?
|
Saphenous Vein | 2 | 2012 | 518 | 0.130 |
Why?
|
National Health Insurance, United States | 1 | 2016 | 100 | 0.130 |
Why?
|
Treatment Failure | 2 | 2015 | 2642 | 0.130 |
Why?
|
Societies, Medical | 3 | 2018 | 3905 | 0.130 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 518 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 213 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 766 | 0.130 |
Why?
|
Propensity Score | 4 | 2022 | 1908 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2015 | 20092 | 0.120 |
Why?
|
Oligonucleotides | 2 | 2008 | 582 | 0.120 |
Why?
|
Subclavian Vein | 1 | 2014 | 58 | 0.120 |
Why?
|
Renal Dialysis | 2 | 2019 | 1801 | 0.120 |
Why?
|
Climate Change | 1 | 2021 | 495 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 790 | 0.120 |
Why?
|
Risk Adjustment | 2 | 2016 | 600 | 0.120 |
Why?
|
Walking | 2 | 2015 | 1200 | 0.120 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.120 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2001 | 1493 | 0.120 |
Why?
|
Subclavian Steal Syndrome | 1 | 2014 | 20 | 0.120 |
Why?
|
Carotid Arteries | 2 | 2015 | 941 | 0.120 |
Why?
|
Obstetrics | 1 | 2021 | 665 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2013 | 5841 | 0.110 |
Why?
|
Axillary Artery | 1 | 2014 | 47 | 0.110 |
Why?
|
Cause of Death | 1 | 2004 | 3685 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 415 | 0.110 |
Why?
|
Cost of Illness | 2 | 2017 | 1935 | 0.110 |
Why?
|
Texas | 1 | 2014 | 405 | 0.110 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 414 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1813 | 0.110 |
Why?
|
Models, Economic | 1 | 2017 | 716 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.110 |
Why?
|
Geographic Information Systems | 1 | 2015 | 281 | 0.110 |
Why?
|
Subcutaneous Fat | 2 | 2013 | 393 | 0.100 |
Why?
|
Hospitals, Military | 3 | 2017 | 62 | 0.100 |
Why?
|
Preoperative Period | 1 | 2015 | 551 | 0.100 |
Why?
|
Health Care Rationing | 1 | 2016 | 437 | 0.100 |
Why?
|
Angiography | 2 | 2016 | 1599 | 0.100 |
Why?
|
Administration, Topical | 1 | 2014 | 703 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1121 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 752 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1212 | 0.100 |
Why?
|
Insurance, Health | 2 | 2017 | 2495 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2016 | 12329 | 0.100 |
Why?
|
Anticoagulants | 1 | 2007 | 4813 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2691 | 0.100 |
Why?
|
Inflammation | 2 | 2013 | 10760 | 0.100 |
Why?
|
Preoperative Care | 3 | 2020 | 2242 | 0.100 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1703 | 0.100 |
Why?
|
Meglumine | 1 | 2012 | 144 | 0.100 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 115 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2015 | 408 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 942 | 0.100 |
Why?
|
Adrenalectomy | 1 | 2013 | 346 | 0.090 |
Why?
|
Prostatectomy | 2 | 2017 | 1824 | 0.090 |
Why?
|
Tanzania | 1 | 2015 | 1387 | 0.090 |
Why?
|
Hospitalization | 2 | 2010 | 10715 | 0.090 |
Why?
|
Ultrasonography, Interventional | 2 | 2010 | 1495 | 0.090 |
Why?
|
Models, Statistical | 2 | 2015 | 5078 | 0.090 |
Why?
|
Young Adult | 9 | 2022 | 59196 | 0.090 |
Why?
|
Caloric Restriction | 1 | 2012 | 299 | 0.090 |
Why?
|
Age Factors | 6 | 2017 | 18401 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.080 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15262 | 0.080 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1257 | 0.080 |
Why?
|
Decompression, Surgical | 1 | 2014 | 608 | 0.080 |
Why?
|
Netherlands | 1 | 2014 | 2220 | 0.080 |
Why?
|
Drug Costs | 1 | 2017 | 1183 | 0.080 |
Why?
|
Database Management Systems | 1 | 2010 | 257 | 0.080 |
Why?
|
Communication | 2 | 2021 | 3870 | 0.080 |
Why?
|
Brachytherapy | 1 | 2016 | 1223 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1668 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1156 | 0.080 |
Why?
|
Aortography | 1 | 2010 | 420 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
Hospital Charges | 1 | 2010 | 351 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2014 | 908 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4432 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 2012 | 648 | 0.080 |
Why?
|
Transplantation, Autologous | 3 | 2009 | 2115 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2523 | 0.080 |
Why?
|
Morbidity | 1 | 2013 | 1750 | 0.080 |
Why?
|
Survival Analysis | 4 | 2015 | 10075 | 0.080 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2013 | 732 | 0.070 |
Why?
|
ROC Curve | 2 | 2013 | 3572 | 0.070 |
Why?
|
Nutritional Status | 1 | 2016 | 1613 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2021 | 4812 | 0.070 |
Why?
|
Pericardium | 1 | 2012 | 675 | 0.070 |
Why?
|
Vascular System Injuries | 1 | 2010 | 246 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1113 | 0.070 |
Why?
|
Adiposity | 1 | 2017 | 1877 | 0.070 |
Why?
|
Prospective Studies | 6 | 2016 | 54405 | 0.070 |
Why?
|
Emergency Medicine | 1 | 2016 | 1196 | 0.070 |
Why?
|
Delayed Graft Function | 1 | 2006 | 53 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2426 | 0.070 |
Why?
|
Photoplethysmography | 1 | 2006 | 60 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3597 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15835 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 2005 | 0.060 |
Why?
|
Pilot Projects | 2 | 2021 | 8632 | 0.060 |
Why?
|
Inguinal Canal | 1 | 2005 | 71 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20555 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6341 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2014 | 1175 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1250 | 0.060 |
Why?
|
Patient Participation | 1 | 2014 | 1443 | 0.060 |
Why?
|
Memory | 1 | 2014 | 2187 | 0.060 |
Why?
|
Anesthesiology | 1 | 2015 | 1117 | 0.060 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 648 | 0.060 |
Why?
|
Radiography | 2 | 2006 | 6966 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3041 | 0.060 |
Why?
|
Adolescent | 5 | 2022 | 88305 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1886 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2421 | 0.060 |
Why?
|
North America | 1 | 2007 | 1275 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3200 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 431 | 0.060 |
Why?
|
Viscera | 1 | 2004 | 138 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4330 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14665 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 2 | 2019 | 954 | 0.060 |
Why?
|
Sex Distribution | 1 | 2008 | 2281 | 0.060 |
Why?
|
Minority Groups | 1 | 2010 | 1203 | 0.050 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2006 | 292 | 0.050 |
Why?
|
Aorta | 1 | 2010 | 2042 | 0.050 |
Why?
|
Probability | 2 | 2005 | 2478 | 0.050 |
Why?
|
Retreatment | 2 | 2016 | 598 | 0.050 |
Why?
|
Resistin | 2 | 2013 | 172 | 0.050 |
Why?
|
Computer Literacy | 1 | 2022 | 44 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2013 | 277 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2007 | 968 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8635 | 0.050 |
Why?
|
Blood Transfusion | 2 | 2019 | 1299 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2035 | 0.050 |
Why?
|
Prevalence | 2 | 2010 | 15719 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 840 | 0.050 |
Why?
|
Hand | 1 | 2006 | 902 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2785 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3310 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2016 | 1097 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1517 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6236 | 0.040 |
Why?
|
Administration, Oral | 1 | 2007 | 4013 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2019 | 34 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2006 | 1496 | 0.040 |
Why?
|
Penicillins | 1 | 2022 | 406 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3356 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4793 | 0.040 |
Why?
|
Information Systems | 1 | 2021 | 396 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5310 | 0.040 |
Why?
|
Graft Rejection | 3 | 2012 | 4446 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13500 | 0.040 |
Why?
|
Insurance Coverage | 2 | 2022 | 1938 | 0.040 |
Why?
|
Permeability | 1 | 2001 | 722 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6901 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 768 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 627 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3687 | 0.040 |
Why?
|
Recurrence | 4 | 2016 | 8470 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1934 | 0.040 |
Why?
|
Ultrasonography, Mammary | 1 | 2020 | 239 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7390 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2004 | 696 | 0.040 |
Why?
|
Occult Blood | 1 | 2018 | 198 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 26108 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2009 | 1852 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4591 | 0.040 |
Why?
|
Endoleak | 1 | 2018 | 111 | 0.040 |
Why?
|
Medicaid | 1 | 2010 | 2817 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 464 | 0.030 |
Why?
|
Smoking | 1 | 2014 | 9051 | 0.030 |
Why?
|
Health Status | 1 | 2010 | 4075 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12972 | 0.030 |
Why?
|
Government Agencies | 1 | 2017 | 160 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1414 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5877 | 0.030 |
Why?
|
Leptin | 2 | 2013 | 1595 | 0.030 |
Why?
|
Massachusetts | 2 | 2022 | 8837 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1596 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5492 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1272 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2018 | 739 | 0.030 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 444 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 931 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1344 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2018 | 491 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 313 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2022 | 22124 | 0.030 |
Why?
|
Physician Assistants | 1 | 2015 | 191 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1665 | 0.030 |
Why?
|
Cell Division | 1 | 2001 | 4466 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2007 | 3956 | 0.030 |
Why?
|
Urinary Incontinence | 1 | 2017 | 489 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 640 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21009 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36430 | 0.030 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2189 | 0.030 |
Why?
|
Efficiency | 1 | 2015 | 476 | 0.030 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 259 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1504 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 873 | 0.020 |
Why?
|
Heart Failure | 2 | 2014 | 11672 | 0.020 |
Why?
|
Hospitals, General | 1 | 2016 | 798 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 385 | 0.020 |
Why?
|
Blood Pressure | 1 | 2006 | 8485 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 879 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2644 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 305 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3025 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 604 | 0.020 |
Why?
|
Prognosis | 2 | 2010 | 29588 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 696 | 0.020 |
Why?
|
Perioperative Care | 1 | 2018 | 1034 | 0.020 |
Why?
|
Aneurysm, False | 1 | 2012 | 254 | 0.020 |
Why?
|
Mammography | 1 | 2020 | 2429 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12710 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2667 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 983 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2016 | 1958 | 0.020 |
Why?
|
Interleukins | 1 | 2013 | 782 | 0.020 |
Why?
|
Fees and Charges | 1 | 2008 | 192 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1887 | 0.020 |
Why?
|
Appendectomy | 1 | 2010 | 433 | 0.020 |
Why?
|
Life Tables | 1 | 2007 | 365 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3460 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6231 | 0.020 |
Why?
|
Adiponectin | 1 | 2013 | 1113 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2008 | 407 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2853 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2007 | 511 | 0.020 |
Why?
|
Cattle | 1 | 2012 | 3849 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42251 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 573 | 0.020 |
Why?
|
Attention | 1 | 2015 | 2395 | 0.020 |
Why?
|
Trauma Centers | 1 | 2010 | 937 | 0.020 |
Why?
|
Brachial Artery | 1 | 2006 | 366 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 461 | 0.020 |
Why?
|
Observer Variation | 1 | 2010 | 2605 | 0.010 |
Why?
|
Models, Biological | 1 | 2001 | 9468 | 0.010 |
Why?
|
Mesenteric Artery, Superior | 1 | 2004 | 95 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7439 | 0.010 |
Why?
|
Forecasting | 1 | 2013 | 2928 | 0.010 |
Why?
|
Equipment Design | 1 | 2012 | 3510 | 0.010 |
Why?
|
Anesthesia | 1 | 2015 | 1592 | 0.010 |
Why?
|
Fingers | 1 | 2006 | 507 | 0.010 |
Why?
|
Colectomy | 1 | 2008 | 688 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2490 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11531 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3210 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6815 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4908 | 0.010 |
Why?
|
Renal Artery | 1 | 2004 | 351 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5428 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5247 | 0.010 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1384 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4355 | 0.010 |
Why?
|
Bariatric Surgery | 1 | 2010 | 991 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7999 | 0.010 |
Why?
|
Animals | 3 | 2012 | 168388 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9319 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29858 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11454 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16603 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9275 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11116 | 0.010 |
Why?
|
Child | 1 | 2022 | 80156 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7049 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36202 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12934 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15499 | 0.000 |
Why?
|